Skip to main content
Register
Hotel Reservations
Schedule
Full Schedule
Browse By Date
PRE-RECORDED
Monday, May 13, 2024
Tuesday, May 14, 2024
Wednesday, May 15, 2024
Thursday, May 16, 2024
Browse By Track
Browse by Session Type
Browse By Speaker
Poster Abstracts
Browse by Title
Browse by Date
Browse by Author
Browse By Track
Sponsors and Exhibitors
Floor Plan
Exhibitor List
AAPS Homepage
Social Media Toolkit
Toggle navigation
Login
Search
Home
Register
Hotel Reservations
+
Schedule
Full Schedule
+
Browse By Date
PRE-RECORDED
Monday, May 13, 2024
Tuesday, May 14, 2024
Wednesday, May 15, 2024
Thursday, May 16, 2024
Browse By Track
Browse by Session Type
Browse By Speaker
+
Poster Abstracts
Browse by Title
Browse by Date
Browse by Author
Browse By Track
+
Sponsors and Exhibitors
Floor Plan
Exhibitor List
AAPS Homepage
Social Media Toolkit
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
20 results found
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Y
Yamaguchi, Katsutoshi
Astellas Pharma Inc.
(
T1030-01-01
)
Development of Physicochemical Profiling Platform for Therapeutic Oligonucleotides
Katsutoshi Yamaguchi
Favorite
(
T1330-01-01
)
Development of Physicochemical Profiling Platform for Therapeutic Oligonucleotides II Circular Dichroism Spectroscopy and Nuclear Magnetic Resonance Analysis for Determining Higher-Order Structure
Katsutoshi Yamaguchi
Favorite
(
W1230-01-01
)
Development of Physicochemical Profiling Platform for Therapeutic Oligonucleotides IV Evaluation of Compactness of Oligonucleotides for Determining Their Higher-Order Structure
Katsutoshi Yamaguchi
Favorite
Yamazaki, Tomohiko
National Institute for Materials Science
(
T1030-01-01
)
Development of Physicochemical Profiling Platform for Therapeutic Oligonucleotides
Tomohiko Yamazaki
Favorite
(
W1430-01-01
)
Development of Physicochemical Profiling Platform for Therapeutic Oligonucleotides V Biological Function Analysis of Oligodeoxynucleotides
Tomohiko Yamazaki
Favorite
Yan, Bingfang
University of Cincinnati
(
T1030-02-10
)
Synthesis a Cationic-Polymer Incorporating Carboxylesterase Active Ester for the Delivery of CRISPR/Cas9 to Ameliorate Hyperlipidemia
Bingfang Yan
Favorite
(
W1030-01-03
)
Oral Delivery of Remdesivir Analogues: Alternatives for Intravenous Remdesivir with Reduced Potential Drug-Drug Interactions
Bingfang Yan
Favorite
Yang, Liu
AstraZeneca
(
W1230-02-09
)
LC-MS FFPE Tissue Analysis Across Multiple Murine Tissues Supports Mouse Relevance for On-Target/Off-Tumor Toxicity Assessment for Anti-STEAP2 CAR-T Therapeutic Development
Liu Yang
Favorite
Yang, Yi
Genentech, Inc.
(
T1430-01-03
)
Val-His-Ser (VHS) N-terminal Leader Sequence and Implications for mAb Subcutaneous Pharmacokinetics
Yi Yang
Favorite
Ye, Wei
AliveX Biotech
(
T1030-02-06
)
A Mechanistic Model of IgG4-RD Identifies High-Potential Therapy Targets
Wei Ye
Favorite
Ying, Xi
Georgia Institute of Technology
(
W1330-01-03
)
Deciphering the Role of Hydrogel Network Topology in Programmably Degradable Hydrogels
Xi Ying
Favorite
Yin, Zhaojun
Genentech, Inc.
(
T1330-02-06
)
Utilizing a Bead-Based Sample Pretreatment to Overcome Drug Interference in Developing a Ligand Binding Neutralizing Antibody Assay
Zhaojun Yin
Favorite
Yoshida, Maki
Chugai Pharmaceutical Co., Ltd.
(
T1230-02-06
)
Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Overview
Maki Yoshida
Favorite
(
T1430-02-06
)
Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Post-Translational Modification (1) C-terminal Lys Clipping
Maki Yoshida
Favorite
(
W1130-02-06
)
Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Post-Translational Modification (2) Oxidation
Maki Yoshida
Favorite
(
W1330-02-06
)
Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Post-Translational Modification (1) Deamidation
Maki Yoshida
Favorite
Yoshimura, Seiji
Astellas Pharma Inc.
(
T1330-01-01
)
Development of Physicochemical Profiling Platform for Therapeutic Oligonucleotides II Circular Dichroism Spectroscopy and Nuclear Magnetic Resonance Analysis for Determining Higher-Order Structure
Seiji Yoshimura
Favorite
(
W1230-01-01
)
Development of Physicochemical Profiling Platform for Therapeutic Oligonucleotides IV Evaluation of Compactness of Oligonucleotides for Determining Their Higher-Order Structure
Seiji Yoshimura
Favorite
Younes, Husam
Qatar University
(
W1330-01-04
)
Prolonged Ocular Delivery of Sunitinib from Poly (diol-tricarballylate) Injectable Biodegradable Elastomeric Tiny Implant for Diabetic Retinopathy Treatment
Husam Younes
Favorite
Yu, Shang-Fan
Genentech, Inc.
(
T1030-02-09
)
Evaluating the Effects of Differently Charged Linker-Drugs on Pharmacokinetics and Tissue Distribution of Antibody Drug Conjugates
Shang-Fan Yu
Favorite
Back to Top
